Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Atyr Pharma Inc (ATYR)

Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Tue Dec 17, 7:00AM CST

ATYR : 3.77 (+10.23%)
aTyr Pharma Appoints Eric Benevich to Board of Directors Quiver Quantitative, Inc. - Fri Dec 13, 1:24AM CST

aTyr Pharma appoints Eric Benevich to its Board of Directors, enhancing commercialization efforts with his extensive industry experience.Quiver AI SummaryaTyr Pharma, Inc. announced the appointment of...

ATYR : 3.77 (+10.23%)
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors GlobeNewswire - Thu Dec 12, 3:00PM CST

ATYR : 3.77 (+10.23%)
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis GlobeNewswire - Tue Dec 10, 7:00AM CST

ATYR : 3.77 (+10.23%)
aTyr Pharma to Present Findings on ATYR0101 as a Novel Anti-Fibrotic Candidate at Keystone Symposia on Fibrosis Quiver Quantitative, Inc. - Mon Dec 9, 5:22PM CST

aTyr Pharma will present findings on its anti-fibrotic candidate ATYR0101 at the Keystone Symposia in December 2024.Quiver AI SummaryaTyr Pharma, Inc. announced that it will present two posters on its...

ATYR : 3.77 (+10.23%)
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis GlobeNewswire - Mon Dec 9, 7:00AM CST

ATYR : 3.77 (+10.23%)
aTyr Pharma to Present Research on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis Quiver Quantitative, Inc. - Fri Nov 15, 5:20PM CST

aTyr Pharma announces poster presentations on tRNA synthetase candidate ATYR0101 at the upcoming Keystone Symposia on Fibrosis.Quiver AI SummaryaTyr Pharma, Inc. announced that it will present two posters...

ATYR : 3.77 (+10.23%)
aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis GlobeNewswire - Fri Nov 15, 7:00AM CST

ATYR : 3.77 (+10.23%)
Atyr Pharma: Q3 Earnings Snapshot AP - Thu Nov 7, 3:52PM CST

Atyr Pharma: Q3 Earnings Snapshot

ATYR : 3.77 (+10.23%)
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update GlobeNewswire - Thu Nov 7, 3:01PM CST

ATYR : 3.77 (+10.23%)

Barchart Exclusives

2 Dow Stocks to Buy in 2025 That Also Pay Dividends Barchart - Thu Dec 26, 6:30PM CST
These dividend-paying stocks could be good additions to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot